Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jane Huang. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jane Huang har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:PRLD / Prelude Therapeutics Incorporated | President, CMO | 80 897 |
US:BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock) | CMO, Hematology | 211 276 |
US:TARA / Protara Therapeutics, Inc. | Director | 10 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jane Huang. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp PRLD / Prelude Therapeutics Incorporated - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i PRLD / Prelude Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i PRLD / Prelude Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|---|---|---|---|
2023-04-06 | PRLD | Huang Jane | 13 280 | 6,1200 | 13 280 | 6,1200 | 81 274 | 208 | 1.6900 | −58 830 | −72,39 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp TARA / Protara Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i PRLD / Prelude Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i PRLD / Prelude Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jane Huang som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 355 | 80 897 | −3,98 | 0,79 | −2 664 | 64 224 | |
2025-07-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 84 252 | 12,52 | ||||
2025-04-07 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 355 | 74 877 | −4,29 | 0,68 | −2 265 | 50 542 | |
2025-04-07 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 78 232 | 13,62 | ||||
2025-01-07 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 859 | 68 857 | −5,31 | 1,39 | −5 364 | 95 711 | |
2025-01-07 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 72 716 | 14,80 | ||||
2024-10-07 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 349 | 63 341 | −5,02 | 2,00 | −6 698 | 126 682 | |
2024-10-07 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 66 690 | 16,36 | ||||
2024-07-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 347 | 57 315 | −5,52 | 3,60 | −12 049 | 206 334 | |
2024-07-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 60 662 | 18,28 | ||||
2024-04-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 347 | 51 287 | −6,13 | 4,74 | −15 865 | 243 100 | |
2024-04-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 54 634 | 20,71 | ||||
2024-01-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 844 | 45 259 | −7,83 | 3,77 | −14 492 | 170 626 | |
2024-01-08 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 49 103 | 23,60 | ||||
2023-10-06 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 39 728 | 30,89 | ||||
2023-07-06 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
F - Taxes | −3 242 | 30 353 | −9,65 | 4,65 | −15 075 | 141 141 | |
2023-07-06 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 9 375 | 33 595 | 38,71 | ||||
2023-04-06 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
S - Sale | −13 280 | 24 220 | −35,41 | 6,12 | −81 274 | 148 226 | |
2023-04-06 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 37 500 | 37 500 | |||||
2022-05-04 |
|
4 | PRLD |
Prelude Therapeutics Inc
Restricted Stock Unit |
A - Award | 150 000 | 150 000 | |||||
2022-05-04 |
|
4 | PRLD |
Prelude Therapeutics Inc
Employee Stock Option (Right to Buy) |
A - Award | 460 000 | 460 000 | |||||
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 211 276 | −8,45 | ||||
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 284,52 | −28 452 | |
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 100 | −66,67 | 281,64 | −56 327 | 28 164 |
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 300 | −25,00 | 278,79 | −27 879 | 83 637 |
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 400 | −55,56 | 278,21 | −139 106 | 111 285 |
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 900 | −25,00 | 276,95 | −83 086 | 249 258 |
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 200 | −20,00 | 274,54 | −82 361 | 329 444 |
2021-12-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 119,96 | 179 940 | 179 940 | ||
2021-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −519 | 0 | −100,00 | 362,45 | −188 112 | ||
2021-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −530 | 519 | −50,52 | 357,32 | −189 381 | 185 451 | |
2021-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
A - Award | 1 049 | 1 049 | |||||
2021-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 14 820 | 160 055 | 10,20 | ||||
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 230 776 | −7,79 | ||||
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 0 | −100,00 | 387,94 | −116 382 | |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 300 | −25,00 | 385,28 | −38 528 | 115 584 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 400 | −20,00 | 384,16 | −38 416 | 153 664 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 500 | −16,67 | 382,42 | −38 242 | 191 210 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 600 | −25,00 | 381,41 | −76 282 | 228 846 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 800 | −11,11 | 379,88 | −37 988 | 303 907 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 900 | −10,00 | 377,92 | −37 792 | 340 128 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 000 | −23,08 | 377,14 | −113 142 | 377 140 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 300 | −13,33 | 376,16 | −75 231 | 489 002 |
2021-11-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 119,96 | 179 940 | 179 940 | ||
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 250 276 | −7,23 | ||||
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 377,71 | −37 771 | |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 100 | −66,67 | 376,36 | −75 272 | 37 636 |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 300 | −57,14 | 375,08 | −150 032 | 112 524 |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 700 | −36,36 | 373,75 | −149 500 | 261 625 |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 100 | −8,33 | 371,65 | −37 165 | 408 815 |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 200 | −7,69 | 370,14 | −37 014 | 444 168 |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 300 | −13,33 | 362,04 | −72 409 | 470 658 |
2021-10-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 119,96 | 179 940 | 179 940 | ||
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −78 000 | 269 776 | −22,43 | ||||
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 411,17 | −41 117 | |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 100 | −50,00 | 408,69 | −40 869 | 40 869 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −150 | 200 | −42,86 | 407,98 | −61 197 | 81 597 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 350 | −36,36 | 406,86 | −81 372 | 142 401 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −583 | 550 | −51,46 | 401,86 | −234 284 | 221 022 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 1 133 | −26,09 | 400,58 | −160 233 | 453 860 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 1 533 | −20,69 | 399,00 | −159 599 | 611 663 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −790 | 1 933 | −29,01 | 398,37 | −314 709 | 770 042 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −700 | 2 723 | −20,45 | 397,15 | −278 004 | 1 081 436 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −700 | 3 423 | −16,98 | 396,00 | −277 200 | 1 355 508 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −913 | 4 123 | −18,13 | 395,13 | −360 756 | 1 629 130 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −328 | 5 036 | −6,11 | 393,34 | −129 016 | 1 980 865 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −536 | 5 364 | −9,08 | 392,40 | −210 327 | 2 104 844 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 5 900 | −1,67 | 390,91 | −39 091 | 2 306 345 |
2021-09-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 6 000 | 6 000 | 119,96 | 719 760 | 719 760 | ||
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 | 0 | −100,00 | 363,45 | −363 | |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 581 | 1 | −99,94 | 362,80 | −573 583 | 363 |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −900 | 1 582 | −36,26 | 361,05 | −324 945 | 571 181 |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 800 | 2 482 | −42,04 | 359,88 | −647 789 | 893 229 |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 700 | 4 282 | −28,42 | 359,15 | −610 552 | 1 537 874 |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 300 | 5 982 | −17,85 | 357,54 | −464 808 | 2 138 832 |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 400 | 7 282 | −16,13 | 356,46 | −499 040 | 2 595 721 |
2021-09-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −4 219 | 8 682 | −32,70 | 355,37 | −1 499 309 | 3 085 328 |
2021-09-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −545 | 0 | −100,00 | 327,18 | −178 314 | ||
2021-09-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
A - Award | 545 | 545 | |||||
2021-09-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −542 | 0 | −100,00 | 310,53 | −168 307 | ||
2021-09-02 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 7 124 | 312 948 | 2,33 | ||||
2021-09-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
A - Award | 542 | 542 | |||||
2021-09-02 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 7 163 | 305 824 | 2,40 | ||||
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −68 315 | 204 971 | −25,00 | ||||
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −114 803 | 347 776 | −24,82 | ||||
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −89 882 | 122 798 | −42,26 | ||||
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −98 | 0 | −100,00 | 335,76 | −32 904 | |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 000 | 98 | −91,07 | 334,85 | −334 846 | 32 815 |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 823 | 1 098 | −72,00 | 333,64 | −941 861 | 366 335 |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −8 177 | 3 921 | −67,59 | 332,71 | −2 720 587 | 1 304 564 |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −6 523 | 12 098 | −35,03 | 331,79 | −2 164 250 | 4 013 965 |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 379 | 18 621 | −11,33 | 330,53 | −786 322 | 6 154 732 |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 5 255 | 21 000 | 33,38 | 174,43 | 916 630 | 3 663 030 | |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 8 831 | 15 745 | 127,73 | 119,96 | 1 059 367 | 1 888 770 | |
2021-07-19 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 6 914 | 6 914 | 160,40 | 1 109 006 | 1 109 006 | ||
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 207 575 | −8,59 | ||||
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 0 | −100,00 | 356,98 | −71 395 | |
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 200 | −60,00 | 355,26 | −106 578 | 71 052 |
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 500 | −28,57 | 352,94 | −70 589 | 176 472 |
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 700 | −36,36 | 351,06 | −140 425 | 245 744 |
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 100 | −8,33 | 349,22 | −34 922 | 384 142 |
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 200 | −20,00 | 347,63 | −104 289 | 417 156 |
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2021-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −425 | 0 | −100,00 | 365,00 | −155 125 | ||
2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −469 | 0 | −100,00 | 325,66 | −152 733 | ||
2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 157 196 | 157 196 | |||||
2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25 350 | 304 186 | 9,09 | ||||
2021-06-10 |
|
4 | TARA |
Protara Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2021-06-10 |
|
4 | TARA |
Protara Therapeutics, Inc.
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2021-06-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −603 | 0 | −100,00 | 351,55 | −211 986 | ||
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −540 | 0 | −100,00 | 362,64 | −195 828 | ||
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
A - Award | 540 | 540 | |||||
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 7 189 | 292 772 | 2,52 | ||||
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 227 075 | −7,91 | ||||
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 359,42 | −35 942 | |
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −147 | 100 | −59,51 | 358,36 | −52 679 | 35 836 |
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −353 | 247 | −58,83 | 357,50 | −126 197 | 88 302 |
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 600 | −33,33 | 356,21 | −106 863 | 213 726 |
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 900 | −35,71 | 354,97 | −177 487 | 319 477 |
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 400 | −6,67 | 352,85 | −35 285 | 493 990 |
2021-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 246 575 | −7,33 | ||||
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 0 | −100,00 | 358,62 | −71 724 | |
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 200 | −60,00 | 356,25 | −106 876 | 71 251 |
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 500 | −44,44 | 355,12 | −142 046 | 177 558 |
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 900 | −25,00 | 353,94 | −106 182 | 318 546 |
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 200 | −14,29 | 352,67 | −70 534 | 423 204 |
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 400 | −6,67 | 350,25 | −35 025 | 490 350 |
2021-05-03 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 266 075 | −6,83 | ||||
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −227 | 0 | −100,00 | 326,29 | −74 067 | |
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 227 | −46,84 | 325,56 | −65 112 | 73 902 |
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −378 | 427 | −46,96 | 324,14 | −122 525 | 138 408 |
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −395 | 805 | −32,92 | 323,31 | −127 706 | 260 262 |
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 200 | −20,00 | 321,94 | −96 582 | 386 328 |
2021-03-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 285 575 | −6,39 | ||||
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −600 | 0 | −100,00 | 322,33 | −193 398 | |
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 600 | −40,00 | 321,21 | −128 485 | 192 728 |
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 000 | −23,08 | 319,67 | −95 902 | 319 673 |
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 300 | −7,14 | 317,52 | −31 752 | 412 776 |
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 400 | −6,67 | 315,62 | −31 562 | 441 868 |
2021-03-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 305 075 | −6,01 | ||||
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 0 | −100,00 | 331,46 | −66 292 | |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 200 | −33,33 | 330,05 | −33 005 | 66 010 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 300 | −25,00 | 326,58 | −32 658 | 97 974 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 400 | −20,00 | 323,85 | −32 385 | 129 540 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 500 | −37,50 | 322,51 | −96 754 | 161 257 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −7 | 800 | −0,87 | 320,81 | −2 246 | 256 648 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −393 | 807 | −32,75 | 319,61 | −125 607 | 257 926 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 200 | −20,00 | 318,48 | −95 545 | 382 182 |
2021-02-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 324 575 | −5,67 | ||||
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 0 | −100,00 | 252,86 | −75 859 | |
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 300 | −50,00 | 251,58 | −75 475 | 75 475 |
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 600 | −25,00 | 249,88 | −49 975 | 149 925 |
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 800 | −20,00 | 247,98 | −49 595 | 198 380 |
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 000 | −23,08 | 246,02 | −73 807 | 246 023 |
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 300 | −13,33 | 244,90 | −48 979 | 318 364 |
2020-12-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 344 075 | −5,36 | ||||
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −96 | 0 | −100,00 | 285,05 | −27 365 | |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 96 | −51,02 | 278,92 | −27 892 | 26 776 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 196 | −33,78 | 277,22 | −27 722 | 54 335 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 296 | −25,25 | 275,45 | −27 545 | 81 533 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 396 | −20,16 | 269,05 | −26 905 | 106 544 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 496 | −37,69 | 266,75 | −80 025 | 132 308 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 796 | −20,08 | 264,50 | −52 900 | 210 542 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 996 | −9,12 | 263,28 | −26 328 | 262 227 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 096 | −15,43 | 262,06 | −52 411 | 287 212 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 296 | −7,16 | 260,06 | −26 006 | 337 038 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −104 | 1 396 | −6,93 | 256,00 | −26 624 | 357 372 |
2020-12-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-11-02 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 363 575 | −5,09 | ||||
2020-11-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 301,51 | −30 151 | |
2020-11-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −139 | 100 | −58,16 | 300,70 | −41 798 | 30 070 |
2020-11-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 261 | 239 | −84,07 | 299,88 | −378 144 | 71 670 |
2020-11-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-10-01 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 383 075 | −4,84 | ||||
2020-10-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −102 | 0 | −100,00 | 283,83 | −28 950 | |
2020-10-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −468 | 102 | −82,11 | 281,75 | −131 859 | 28 739 |
2020-10-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −730 | 570 | −56,15 | 280,65 | −204 875 | 159 971 |
2020-10-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 300 | −13,33 | 274,42 | −54 884 | 356 746 |
2020-10-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-09-08 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −217 | 0 | −100,00 | 235,21 | −51 041 | |
2020-09-08 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 217 | −69,74 | 234,17 | −117 085 | 50 815 |
2020-09-08 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 411 | 717 | −66,31 | 232,94 | −328 672 | 167 015 |
2020-09-08 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 000 | 2 128 | −31,97 | 232,25 | −232 247 | 494 221 |
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −39 000 | 402 575 | −8,83 | ||||
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 0 | −100,00 | 244,93 | −73 478 | |
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −700 | 300 | −70,00 | 243,49 | −170 442 | 73 047 |
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 000 | 1 000 | −50,00 | 242,41 | −242 413 | 242 413 |
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 2 000 | −9,09 | 240,86 | −48 172 | 481 720 |
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −800 | 2 200 | −26,67 | 240,15 | −192 121 | 528 334 |
2020-09-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 3 000 | 3 000 | 29,49 | 88 470 | 88 470 | ||
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 212 680 | −8,40 | ||||
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 212 680 | −8,40 | ||||
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −399 | 0 | −100,00 | 213,56 | −85 210 | |
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 399 | −50,06 | 212,53 | −85 011 | 84 798 |
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 799 | −20,02 | 211,31 | −42 262 | 168 837 |
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −700 | 999 | −41,20 | 208,91 | −146 237 | 208 701 |
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 301 | 1 699 | −43,37 | 208,35 | −271 067 | 353 991 |
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 3 000 | 100,00 | 160,40 | 240 600 | 481 200 | |
2020-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-07-09 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −50 973 | 232 180 | −18,00 | ||||
2020-07-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −3 921 | 0 | −100,00 | 200,00 | −784 200 | |
2020-07-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 3 921 | 3 921 | 160,40 | 628 928 | 628 928 | ||
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 461 075 | −4,06 | ||||
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 193,56 | −19 356 | |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −198 | 100 | −66,44 | 192,72 | −38 158 | 19 272 |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 298 | −62,66 | 191,37 | −95 685 | 57 028 |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −402 | 798 | −33,50 | 188,95 | −75 959 | 150 784 |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 1 200 | −20,00 | 187,91 | −56 373 | 225 492 |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −435 | 0 | −100,00 | 192,46 | −83 720 | |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −27 027 | 283 153 | −8,71 | ||||
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −700 | 0 | −100,00 | 200,30 | −140 208 | |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −700 | 700 | −50,00 | 200,29 | −140 204 | 140 204 |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −679 | 1 400 | −32,66 | 200,27 | −135 985 | 280 381 |
2020-06-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 2 079 | 2 079 | 160,40 | 333 472 | 333 472 | ||
2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 273 286 | 273 286 | |||||
2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 48 438 | 331 902 | 17,09 | ||||
2020-06-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −631 | 0 | −100,00 | 170,84 | −107 800 | ||
2020-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 480 575 | −3,90 | ||||
2020-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −431 | 0 | −100,00 | 165,12 | −71 168 | |
2020-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −569 | 431 | −56,90 | 163,97 | −93 300 | 70 672 |
2020-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 1 000 | −33,33 | 162,63 | −81 316 | 162 632 |
2020-06-02 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-04-30 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 500 075 | −3,75 | ||||
2020-04-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 500 | 0 | −100,00 | 162,30 | −243 450 | |
2020-04-30 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-04-17 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 519 575 | −3,62 | ||||
2020-04-17 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 500 | 0 | −100,00 | 160,00 | −240 000 | |
2020-04-17 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-02-20 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 539 075 | −3,49 | ||||
2020-02-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −321 | 0 | −100,00 | 171,14 | −54 935 | |
2020-02-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 179 | 321 | −78,60 | 170,01 | −200 445 | 54 574 |
2020-02-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2020-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 558 575 | −3,37 | ||||
2020-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −87 | 0 | −100,00 | 172,34 | −14 994 | |
2020-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −600 | 87 | −87,34 | 171,27 | −102 762 | 14 900 |
2020-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −813 | 687 | −54,20 | 170,09 | −138 287 | 116 855 |
2020-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 578 075 | −3,26 | ||||
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 173,59 | −17 359 | |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 100 | −50,00 | 172,13 | −17 213 | 17 213 |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 200 | −50,00 | 170,72 | −34 145 | 34 145 |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 400 | −20,00 | 168,90 | −16 890 | 67 560 |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 500 | −16,67 | 165,55 | −16 555 | 82 775 |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −800 | 600 | −57,14 | 161,93 | −129 541 | 97 156 |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 1 400 | −6,67 | 160,07 | −16 007 | 224 098 |
2019-12-18 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 597 575 | −3,16 | ||||
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −100 | 0 | −100,00 | 198,93 | −19 893 | |
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −95 | 100 | −48,72 | 195,82 | −18 603 | 19 582 |
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −605 | 195 | −75,62 | 195,01 | −117 983 | 38 028 |
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 800 | −38,46 | 193,63 | −96 813 | 154 901 |
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −200 | 1 300 | −13,33 | 192,24 | −38 448 | 249 912 |
2019-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,49 | 44 235 | 44 235 | ||
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 427 700 | 617 075 | 225,85 | ||||
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 0 | −100,00 | 192,77 | −57 831 | |
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 854 | 300 | −90,49 | 191,96 | −547 844 | 57 587 |
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −12 654 | 3 154 | −80,05 | 191,01 | −2 417 011 | 602 438 |
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −12 523 | 15 808 | −44,20 | 190,00 | −2 379 399 | 3 003 556 |
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −4 569 | 28 331 | −13,89 | 189,08 | −863 921 | 5 356 916 |
2019-11-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 32 900 | 32 900 | 29,49 | 970 221 | 970 221 | ||
2019-09-05 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −82 | 0 | −100,00 | 129,40 | −10 611 | |
2019-09-05 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −230 | 0 | −100,00 | 144,94 | −33 337 | |
2019-09-05 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 632 | 230 | −91,96 | 144,41 | −380 083 | 33 214 |
2019-08-13 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 32 500 | 850 465 | 3,97 | ||||
2019-08-13 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −500 | 0 | −100,00 | 136,91 | −68 454 | |
2019-08-13 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −800 | 500 | −61,54 | 135,86 | −108 686 | 67 928 |
2019-08-13 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −400 | 1 300 | −23,53 | 134,34 | −53 736 | 174 642 |
2019-08-13 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −800 | 1 700 | −32,00 | 132,47 | −105 979 | 225 206 |
2019-08-13 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 2 500 | 2 500 | 45,31 | 113 275 | 113 275 | ||
2019-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 66 690 | 1 044 775 | 6,82 | ||||
2019-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 65 000 | 882 965 | 7,95 | ||||
2019-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −7 630 | 0 | −100,00 | 135,10 | −1 030 821 | |
2019-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 500 | 7 630 | −24,68 | 132,83 | −332 075 | 1 013 493 |
2019-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 5 130 | 10 130 | 102,60 | 29,49 | 151 284 | 298 734 | |
2019-07-31 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 5 000 | 5 000 | 45,31 | 226 550 | 226 550 | ||
2019-07-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −3 | 0 | −100,00 | 126,33 | −379 | |
2019-07-01 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −427 | 3 | −99,30 | 124,50 | −53 163 | 374 |
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 462 579 | 462 579 | |||||
2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 62 842 | 334 463 | 23,14 | ||||
2019-05-22 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 28 600 | 947 965 | 3,11 | ||||
2019-05-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 200 | 0 | −100,00 | 130,06 | −286 132 | |
2019-05-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 2 200 | 2 200 | 45,31 | 99 682 | 99 682 | ||
2019-05-22 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 3 900 | 976 565 | 0,40 | ||||
2019-05-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −300 | 0 | −100,00 | 130,12 | −39 036 | |
2019-05-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 300 | 300 | 45,31 | 13 593 | 13 593 | ||
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 183 690 | 1 111 465 | 19,80 | ||||
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −147 | 0 | −100,00 | 145,94 | −21 453 | |
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 281 | 147 | −89,71 | 144,90 | −185 617 | 21 300 |
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 304 | 1 428 | −61,74 | 143,72 | −331 132 | 205 233 |
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −6 159 | 3 732 | −62,27 | 142,73 | −879 060 | 532 660 |
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −3 439 | 9 891 | −25,80 | 141,80 | −487 662 | 1 402 576 |
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −800 | 13 330 | −5,66 | 140,49 | −112 390 | 1 872 698 |
2019-04-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 14 130 | 14 130 | 29,49 | 416 694 | 416 694 | ||
2019-03-11 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 33 345 | 1 295 155 | 2,64 | ||||
2019-03-11 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 565 | 0 | −100,00 | 130,00 | −333 450 | |
2019-03-11 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 2 565 | 2 565 | 29,49 | 75 642 | 75 642 | ||
2019-03-11 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −71 | 0 | −100,00 | 140,50 | −9 976 | |
2018-11-28 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | 39 000 | 1 328 500 | 3,02 | ||||
2018-11-28 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −3 000 | 0 | −100,00 | 139,58 | −418 750 | |
2018-11-28 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 3 000 | 3 000 | 29,49 | 88 470 | 88 470 | ||
2018-09-05 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −2 911 | 0 | −100,00 | 174,60 | −508 247 | |
2018-06-28 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 310 180 | 310 180 | |||||
2018-06-28 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 44 564 | 309 464 | 16,82 | ||||
2017-12-22 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −13 000 | 1 367 500 | −0,94 | ||||
2017-12-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −1 000 | 0 | −100,00 | 98,00 | −98 000 | ||
2017-12-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 000 | 1 000 | 29,51 | 29 510 | 29 510 | ||
2017-12-15 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
M - Exercise | −19 500 | 1 380 500 | −1,39 | ||||
2017-12-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −200 | 0 | −100,00 | 94,53 | −18 906 | ||
2017-12-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | −1 300 | 200 | −86,67 | 94,21 | −122 475 | 18 842 | |
2017-12-15 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
M - Exercise | 1 500 | 1 500 | 29,51 | 44 265 | 44 265 | ||
2017-12-05 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 100 | 0 | −100,00 | 86,00 | −94 600 | |
2017-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −1 000 | 1 100 | −47,62 | 87,00 | −87 000 | 95 700 |
2017-11-20 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | X | −600 | 2 100 | −22,22 | 85,00 | −51 000 | 178 500 |
2017-06-29 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 980 465 | 980 465 | |||||
2016-09-07 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 1 400 000 | 1 400 000 | |||||
2016-09-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 300 000 | 300 000 |